Close this search box.

How Dexcom and Abbott are using blood sugar monitoring to go beyond diabetes?


Diabetes, a chronic condition characterized by the body’s inability to produce enough insulin or use it effectively, has become a significant health concern in the United States. With over 37 million individuals affected, comprising more than 11% of the country’s population, it is crucial to develop innovative solutions to manage the disease effectively.

Traditionally, individuals with diabetes have relied on glucometers, which involve pricking their fingers multiple times a day to measure their blood sugar levels. However, advancements in technology over the past decade have introduced continuous glucose monitoring (CGM) systems, revolutionizing diabetes management.

Leading players in the CGM space include Abbott and Dexcom, both of which have experienced notable growth in recent years. These companies have introduced state-of-the-art CGM devices that provide real-time monitoring of blood glucose levels, eliminating the need for frequent finger pricks. The devices consist of small sensors inserted under the skin that measure glucose levels and transmit the data to a receiver or smartphone app.

Interestingly, the benefits of CGM technology are not limited to individuals with diabetes alone. Health and wellness apps have started incorporating CGM features, catering to a wider audience. These apps leverage the continuous monitoring capabilities to offer valuable insights into blood sugar trends, helping users make informed decisions about their nutrition, exercise, and overall well-being.

In a recent interview with CNBC, representatives from Abbott and Dexcom shed light on the technology behind CGM devices and their visions for future expansion. Both companies foresee continued growth and advancements in CGM technology, aiming to improve the lives of individuals with diabetes while exploring opportunities to serve non-diabetic users seeking to optimize their health.

As the prevalence of diabetes continues to rise, the development and adoption of innovative technologies like CGM offer hope for better management, enhanced quality of life, and improved health outcomes for millions of individuals affected by this chronic condition.

Read More news: Click here



Copyright 2023 © Insightscare Magazine ( a Digital Ink brand ) All rights reserved.